Faisa Guled
Analyst
- Name
- Ing. F. Guled MSc
- Telephone
- +31 71 527 2463
- guledf@chem.leidenuniv.nl
Analyst
- Faculty of Science
- Leiden Academic Centre for Drug Research
- LACDR/Analytical biosciences
- Hosseinkhani F., Huang L., Dubbelman A.C., Guled F., Harms A.C. & Hankemeier T. (2022), Systematic evaluation of HILIC stationary phases for global metabolomics of human plasma, Metabolites 12(2): 165.
- He B.S., Di X., Gulded F., Harder A.V.E., Maagdenberg A.M.J.M. van den, Terwindt G.M., Krekels E.H.J., Kohler I., Harms A.C., Ramautar R. & Hankemeier T. (2022), Quantification of endocannabinoids in human cerebrospinal fluid using a novel micro-flow liquid chromatography-mass spectrometry method, Analytica Chimica Acta 1210: 339888.
- He Y.P., Miggiels A.L.W., Wouters B., Drouin N.F.P., Guled F., Hankemeier T. & Lindenburg P.W. (2021), A high-throughput, ultrafast, and online three-phase electro-extraction method for analysis of trace level pharmaceuticals, Analytica Chimica Acta 1149: 338204.
- Mever M. van, Segers K.R.H., Drouin N.F.P., Guled F., Vander Heyden Y., Van Eeckhaut A., Hankemeier T. & Ramautar R. (2020), Direct profiling of endogenous metabolites in rat brain microdialysis samples by capillary electrophoresis-mass spectrometry with on-line preconcentration, 156: 104949.
- Zhang W., Guled F., Hankemeier T. & Ramautar R. (2020), Profiling nucleotides in low numbers of mammalian cells by sheathless CE-MS in positive ion mode: Circumventing corona discharge, Electrophoresis 41(5-6): 360-369.
- Zhang W., Guled F., Hankemeier T. & Ramautar R. (2019), Utility of sheathless capillary electrophoresis-mass spectrometry for metabolic profiling of limited sample amounts, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 1105: 10-14.
- Ellero-Simatos S., Beitelshees A.L., Lewis J.P., Yerges-Armstrong L.M., Georgiades A., Dane A., Harms A.C., Strassburg K., Guled F., Hendriks M.M., Horenstein R.B., Shuldiner A.R., Hankemeier T. & Kaddurah-Daouk R. (2015), Oxylipid profile of low-dose exposure: a pharmacometabolomics study, Clinical Pharmacology & Therapeutics 97(S1): S22-S22.
- Ellero-Simatos S., Beitelshees A.L., Lewis J.P., Yerges-Armstrong L.M., Georgiades A., Dane A.D., Harms A.C., Strassburg K., Guled F., Hendriks M.M.W.B., Horenstein R.B., Shuldiner A.R., Hankemeier T. & Kaddurah-Daouk R. (2015), Oxylipid profile of low-dose aspirin exposure: a pharmacometabolomics study, Journal of the American Heart Association 4(10): e002203.